Skip to main content
Erschienen in: Journal of Gastroenterology 11/2015

01.11.2015 | Original Article—Alimentary Tract

Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation

verfasst von: Min Yu, Songwei Yang, Yuan Qiu, Guoqing Chen, Wensheng Wang, Chao Xu, Wenqiang Cai, Lihua Sun, Weidong Xiao, Hua Yang

Erschienen in: Journal of Gastroenterology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Tight junctions play a critical role in the maintenance of intestinal barrier function. Partitioning-defective protein 3 (Par-3) can regulate intestinal barrier function through the modulation of tight junction assembly and cell polarity. However, the mechanisms are still not fully understood.

Methods

Adult C57BL/6 mice were treated with dextran sulfate sodium for 7 days, and segments of colon were harvested for immunofluorescent staining of Par-3. Caco-2 intestinal epithelial cells were treated with tumor necrosis factor α (TNF-α) for 24 h, and Par-3 expression was detected by Western blot analysis and immunofluorescence. Additionally, Caco-2 cells were treated with Par-3 small interfering RNA, and altered expression and subcellular localization of tight junction proteins were studied by Western blot analysis and immunofluorescence. Furthermore, the interaction between Par-3 and myosin light chain (MLC) was detected by immunoprecipitation.

Results

Par-3 was downregulated in murine dextran sulfate sodium induced acute inflammation and TNF-α-treated Caco-2 cells. Depletion of Par-3 expression by small interfering RNA delayed intestinal epithelial barrier development in Caco-2 cells. This regulation was due to the redistribution of the tight junction protein occludin rather than the altered total levels of tight junction proteins. Par-3 silencing blocked the trafficking of occludin from or through the Golgi complex to the cell surface, and dramatically induced occludin accumulated at the Golgi complex. Importantly, Par-3 can interact with MLC, and loss of Par-3 upregulated MLC kinase expression and MLC phosphorylation, which contributed to intestinal epithelial barrier dysfunction.

Conclusions

These results indicate that Par-3 plays an important role in the modulation of intestinal barrier function by regulating delivery of occludin as well as suppression of MLC phosphorylation.
Literatur
1.
Zurück zum Zitat Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci. 2012;1258:34–42.PubMedCentralCrossRefPubMed Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci. 2012;1258:34–42.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 2000;279:G851–7.PubMed Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 2000;279:G851–7.PubMed
3.
4.
Zurück zum Zitat Visser J, Rozing J, Sapone A, et al. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009;1165:195–205.PubMedCentralCrossRefPubMed Visser J, Rozing J, Sapone A, et al. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009;1165:195–205.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Gonzalez-Mariscal L, Betanzos A, Nava P, et al. Tight junction proteins. Prog Biophys Mol Biol. 2003;81:1–44.CrossRefPubMed Gonzalez-Mariscal L, Betanzos A, Nava P, et al. Tight junction proteins. Prog Biophys Mol Biol. 2003;81:1–44.CrossRefPubMed
6.
Zurück zum Zitat Paris L, Tonutti L, Vannini C, et al. Structural organization of the tight junctions. Biochim Biophys Acta. 2008;1778:646–59.CrossRefPubMed Paris L, Tonutti L, Vannini C, et al. Structural organization of the tight junctions. Biochim Biophys Acta. 2008;1778:646–59.CrossRefPubMed
7.
Zurück zum Zitat Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006;22:207–35.CrossRefPubMed Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006;22:207–35.CrossRefPubMed
8.
Zurück zum Zitat Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23:379–83.CrossRefPubMed Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23:379–83.CrossRefPubMed
9.
Zurück zum Zitat Stallmach A, Giese T, Schmidt C, et al. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease. Int J Colorectal Dis. 2004;19:308–15.CrossRefPubMed Stallmach A, Giese T, Schmidt C, et al. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease. Int J Colorectal Dis. 2004;19:308–15.CrossRefPubMed
11.
Zurück zum Zitat Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171:6164–72.CrossRefPubMed Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171:6164–72.CrossRefPubMed
12.
Zurück zum Zitat Koch S, Nusrat A. Dynamic regulation of epithelial cell fate and barrier function by intercellular junctions. Ann N Y Acad Sci. 2009;1165:220–7.CrossRefPubMed Koch S, Nusrat A. Dynamic regulation of epithelial cell fate and barrier function by intercellular junctions. Ann N Y Acad Sci. 2009;1165:220–7.CrossRefPubMed
13.
Zurück zum Zitat Marano CW, Lewis SA, Garulacan LA, et al. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol. 1998;161:263–74.CrossRefPubMed Marano CW, Lewis SA, Garulacan LA, et al. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol. 1998;161:263–74.CrossRefPubMed
14.
Zurück zum Zitat Youakim A, Ahdieh M. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol. 1999;276:G1279–88.PubMed Youakim A, Ahdieh M. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol. 1999;276:G1279–88.PubMed
15.
Zurück zum Zitat Bruewer M, Utech M, Ivanov AI, et al. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 2005;19:923–33.CrossRefPubMed Bruewer M, Utech M, Ivanov AI, et al. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 2005;19:923–33.CrossRefPubMed
16.
Zurück zum Zitat Yang S, Yu M, Sun L, et al. Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interferon Cytokine Res. 2014;34:195–203.CrossRefPubMed Yang S, Yu M, Sun L, et al. Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interferon Cytokine Res. 2014;34:195–203.CrossRefPubMed
17.
Zurück zum Zitat Schumann M, Gunzel D, Buergel N, et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut. 2012;61:220–8.CrossRefPubMed Schumann M, Gunzel D, Buergel N, et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut. 2012;61:220–8.CrossRefPubMed
18.
Zurück zum Zitat Joberty G, Petersen C, Gao L, et al. The cell-polarity protein Par-6 links Par-3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2000;2:531–9.CrossRefPubMed Joberty G, Petersen C, Gao L, et al. The cell-polarity protein Par-6 links Par-3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2000;2:531–9.CrossRefPubMed
19.
Zurück zum Zitat Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2008;57:463–7.CrossRefPubMed Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2008;57:463–7.CrossRefPubMed
20.
Zurück zum Zitat Chen X, Macara IG. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat Cell Biol. 2005;7:262–9.CrossRefPubMed Chen X, Macara IG. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat Cell Biol. 2005;7:262–9.CrossRefPubMed
21.
Zurück zum Zitat Wells CL, van de Westerlo EM, Jechorek RP, et al. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infect Immun. 1998;66:2410–9.PubMedCentralPubMed Wells CL, van de Westerlo EM, Jechorek RP, et al. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infect Immun. 1998;66:2410–9.PubMedCentralPubMed
22.
Zurück zum Zitat Melgar S, Karlsson L, Rehnstrom E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008;8:836–44.CrossRefPubMed Melgar S, Karlsson L, Rehnstrom E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008;8:836–44.CrossRefPubMed
23.
Zurück zum Zitat Fries W, Muja C, Crisafulli C, et al. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol. 2008;294:G938–47.CrossRefPubMed Fries W, Muja C, Crisafulli C, et al. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol. 2008;294:G938–47.CrossRefPubMed
24.
Zurück zum Zitat Suenaert P, Bulteel V, Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol. 2002;97(8):2000–4.CrossRefPubMed Suenaert P, Bulteel V, Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol. 2002;97(8):2000–4.CrossRefPubMed
25.
Zurück zum Zitat Marchiando AM, Shen L, Graham WV, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010;189:111–26.PubMedCentralCrossRefPubMed Marchiando AM, Shen L, Graham WV, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010;189:111–26.PubMedCentralCrossRefPubMed
26.
27.
Zurück zum Zitat Shen L, Black ED, Witkowski ED, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119:2095–106.CrossRefPubMed Shen L, Black ED, Witkowski ED, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119:2095–106.CrossRefPubMed
28.
Zurück zum Zitat Chen J, Zhang M. The Par-3/Par-6/aPKC complex and epithelial cell polarity. Exp Cell Res. 2013;319:1357–64.CrossRefPubMed Chen J, Zhang M. The Par-3/Par-6/aPKC complex and epithelial cell polarity. Exp Cell Res. 2013;319:1357–64.CrossRefPubMed
29.
Zurück zum Zitat Gopalakrishnan S, Hallett MA, Atkinson SJ, et al. aPKC-PAR complex dysfunction and tight junction disassembly in renal epithelial cells during ATP depletion. Am J Physiol Cell Physiol. 2007;292:C1094–102.CrossRefPubMed Gopalakrishnan S, Hallett MA, Atkinson SJ, et al. aPKC-PAR complex dysfunction and tight junction disassembly in renal epithelial cells during ATP depletion. Am J Physiol Cell Physiol. 2007;292:C1094–102.CrossRefPubMed
30.
Zurück zum Zitat McCaffrey LM, Montalbano J, Mihai C, et al. Loss of the Par-3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell. 2012;22:601–14.PubMedCentralCrossRefPubMed McCaffrey LM, Montalbano J, Mihai C, et al. Loss of the Par-3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell. 2012;22:601–14.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Nighot PK, Blikslager AT. Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol. 2012;302:C178–87.CrossRefPubMed Nighot PK, Blikslager AT. Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol. 2012;302:C178–87.CrossRefPubMed
32.
Zurück zum Zitat Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134:1031–49.CrossRefPubMed Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134:1031–49.CrossRefPubMed
33.
Zurück zum Zitat Yu AS, McCarthy KM, Francis SA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol. 2005;288:C1231–41.CrossRefPubMed Yu AS, McCarthy KM, Francis SA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol. 2005;288:C1231–41.CrossRefPubMed
34.
Zurück zum Zitat McCarthy KM, Skare IB, Stankewich MC, et al. Occludin is a functional component of the tight junction. J Cell Sci. 1996;109:2287–98.PubMed McCarthy KM, Skare IB, Stankewich MC, et al. Occludin is a functional component of the tight junction. J Cell Sci. 1996;109:2287–98.PubMed
35.
Zurück zum Zitat Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol. 1997;136:399–409.PubMedCentralCrossRefPubMed Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol. 1997;136:399–409.PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000;11:4131–42.PubMedCentralCrossRefPubMed Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000;11:4131–42.PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Raleigh DR, Marchiando AM, Zhang Y, et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell. 2010;21:1200–13.PubMedCentralCrossRefPubMed Raleigh DR, Marchiando AM, Zhang Y, et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell. 2010;21:1200–13.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Ivanov AI, Nusrat A, Parkos CA. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell. 2004;15:176–88.PubMedCentralCrossRefPubMed Ivanov AI, Nusrat A, Parkos CA. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell. 2004;15:176–88.PubMedCentralCrossRefPubMed
39.
40.
Zurück zum Zitat Kienzle C, von Blume J. Secretory cargo sorting at the trans-Golgi network. Trends Cell Biol. 2014;24:584–93.CrossRefPubMed Kienzle C, von Blume J. Secretory cargo sorting at the trans-Golgi network. Trends Cell Biol. 2014;24:584–93.CrossRefPubMed
41.
Zurück zum Zitat Wakana Y, van Galen J, Meissner F, et al. A new class of carriers that transport selective cargo from the trans Golgi network to the cell surface. EMBO J. 2012;31:3976–90.PubMedCentralCrossRefPubMed Wakana Y, van Galen J, Meissner F, et al. A new class of carriers that transport selective cargo from the trans Golgi network to the cell surface. EMBO J. 2012;31:3976–90.PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Jin Y, Atkinson SJ, Marrs JA, et al. Myosin II light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1. J Biol Chem. 2001;276:30342–9.PubMedCentralCrossRefPubMed Jin Y, Atkinson SJ, Marrs JA, et al. Myosin II light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1. J Biol Chem. 2001;276:30342–9.PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Matsui T, Watanabe T, Matsuzawa K, et al. PAR-3 and aPKC regulate Golgi organization through CLASP2 phosphorylation to generate cell polarity. Mol Biol Cell. 2015;26:751–61.PubMedCentralCrossRefPubMed Matsui T, Watanabe T, Matsuzawa K, et al. PAR-3 and aPKC regulate Golgi organization through CLASP2 phosphorylation to generate cell polarity. Mol Biol Cell. 2015;26:751–61.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Odell AF, Hollstein M, Ponnambalam S, et al. A VE-cadherin–PAR-3–α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A2α in endothelial cells. Mol Biol Cell. 2012;23:1783–96.PubMedCentralCrossRefPubMed Odell AF, Hollstein M, Ponnambalam S, et al. A VE-cadherin–PAR-3–α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A2α in endothelial cells. Mol Biol Cell. 2012;23:1783–96.PubMedCentralCrossRefPubMed
Metadaten
Titel
Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation
verfasst von
Min Yu
Songwei Yang
Yuan Qiu
Guoqing Chen
Wensheng Wang
Chao Xu
Wenqiang Cai
Lihua Sun
Weidong Xiao
Hua Yang
Publikationsdatum
01.11.2015
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 11/2015
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-015-1066-z

Weitere Artikel der Ausgabe 11/2015

Journal of Gastroenterology 11/2015 Zur Ausgabe

Original Article—Liver, Pancreas, and Biliary Tract

Biphasic effect of alcohol intake on the development of fatty liver disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.